Bobby Arash | Fieldfisher
Skip to main content
Professional background

Professional background

I am a partner in Fieldfisher’s EU Regulatory practice, advising clients on complex EU and national regulatory frameworks. With a background in molecular biology and chemistry and over 20 years’ legal and regulatory experience from public and private sectors, I support businesses operating in highly regulated sectors, with a particular focus on regulated products, compliance strategies and supply chain governance.

I advise across the life sciences, chemicals, technology and industrial sectors on product regulation, environmental and administrative law, EHS compliance and regulatory enforcement, and regularly represent clients in litigation before EU and national courts and regulatory bodies.

Before joining Fieldfisher, I held senior roles within the European Commission, national authorities, industry and international law firms. I hold an LLM and an MSc in Molecular Biology from Stockholm University and am a member of the Swedish Bar Association.

I am fluent in English and Swedish.

 

Authored pieces

All Resources
A close-up view of a multi-channel pipette dispensing liquid samples into a 96-well plate. The tips of the pipette are seen aligned above the plate, ready to transfer the liquid, with a blue and purple background emphasizing the laboratory setting.
EU Regulatory, Competition and Trade
Insight

Updated Article 95 list under the biocidal products regulation; free-riding concerns persist

27.02.2026
On 20 February 2026, the European Chemicals Agency (ECHA)   published an updated Article 95 list of active substances and suppliers (the "Article 95 list") under the Biocidal Products Regulation ("BPR"), including new entries dated through 20 February 2026.
Learn more
A blurred image of a hospital hallway with bright lighting, showing a person in medical scrubs walking in the distance. The scene appears clean and modern, with blue and white tones.
EU Regulatory, Competition and Trade
Insight

Breaking the bottleneck: the Commission's proposal for targeted MDR/IVDR amendments to address implementation challenges

24.02.2026
Learn more